Clinical Trial Update: A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight [Phase 3]

View source ↗

Summary

Phase 3 long-term trial of tirzepatide in adults with Type 1 diabetes mellitus and obesity, with the study status listed as active, not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Drugs mentioned

• MOUNJARO (tirzepatide)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes, Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING